Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination

Name: Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination
License: Public Domain

Changchun BCHT Biotechnology Co.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

prevention of influenza

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 249657
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.